Monday, 17 October 2011 00:27
EKR Therapeutics, Inc. a privately held specialty pharmaceutical company, announced today that Rolf A. Classon, chairman of the board and independent director, will not stand for reelection and has resigned effective immediately.
“Rolf brought tremendous range of depth and experience to the company in this role. We’ve been privileged to have been guided by his wisdom,” says John Bailye, EKR’s President and Chief Executive Officer.
About EKR Therapeutics, Inc.
Since its inception, EKR has focused on acute-care hospital products and continues to actively pursue new opportunities in the hospital space. With its experienced field force of sales professionals, along with its commitment to excellence in customer service and medical education, EKR is leading the way as a provider of acute-care specialty products. For additional information about EKR, visit the company’s website at www.ekrtx.com.
source:EKR Therapeutics, Inc.